Regeneus Ltd (ASX: RGS) merged with Cambium Medical Technologies creating Cambium Bio Limited (ASX:CMB), focusing on dry eye and ophthalmology. For more information about the Company and its programs, please visit www.cambium.bio
View Top Employees from Regeneus LtdWebsite | https://www.cambium.bio |
Ticker | RGS |
Revenue | $476000 |
Employees | 12 (12 on RocketReach) |
Founded | 2007 |
Address | 25 Bridge Street, Pymble, New South Wales 2073, AU |
Phone | +61 2 9499 8010 |
Fax | +61 2 9499 8020 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biotechnology, Business Services, Drug Discovery |
Web Rank | 18 Million |
Keywords | Regeneus, Leo Lee Regeneus |
Competitors | DiscGenics, InGeneron, Sernova Corp., VIDEREGEN LIMITED, ViaCyte |
SIC | SIC Code 87 Companies, SIC Code 873 Companies |
NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies, NAICS Code 5417 Companies |
Looking for a particular Regeneus Ltd employee's phone or email?
The Regeneus Ltd annual revenue was $476000 in 2024.
Karolis Rosickas is the CEO of Regeneus Ltd.
12 people are employed at Regeneus Ltd.
Regeneus Ltd is based in Pymble, New South Wales.
The NAICS codes for Regeneus Ltd are [54171, 54, 541714, 541, 5417].
The SIC codes for Regeneus Ltd are [87, 873].